ESOPJun 12, 2026, 04:06 PM
Cartesian Therapeutics Grants 6,100 Stock Options to New Employee
AI Summary
Cartesian Therapeutics, Inc. announced the granting of an inducement award to a new employee. On June 8, 2026, the company issued an option to purchase 6,100 shares of its common stock at an exercise price of $5.86 per share. This option, approved by the board of directors, vests 25% on June 8, 2027, and then in substantially equal monthly installments over the next three years, fully vesting by June 8, 2030. The award was granted under Nasdaq Listing Rules as a material inducement for the employee's entry into employment.
Key Highlights
- Option to purchase 6,100 shares of common stock granted to a new employee.
- Exercise price set at $5.86 per share, the closing price on grant date.
- Option granted on June 8, 2026, under the 2018 Employment Inducement Incentive Award Plan.
- Vests 25% on June 8, 2027, with remaining vesting in 36 equal monthly installments.
- Option will be fully vested on June 8, 2030, and has a ten-year term.
- Awarded as an inducement material to the employee's entry into employment.
Price Impact
More from RNAC